InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K with the SEC for the month of April 2024. The filing was submitted on April 1, 2024, under Commission File Number 001-40614. The company reports its annual filings on Form 20-F.
The filing identifies Exhibit 99.1 as a press release dated April 1, 2024, but the provided filing text does not include the press release’s substantive contents.
Financial Metrics
The provided text does not disclose clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes and Outlook
The filing text does not provide sufficient information to assess changes versus a prior comparable period, management guidance, outlook, risks, contingencies, or unusual items.
Key Facts to Verify
- Obtain and review Exhibit 99.1, the April 1, 2024 press release.
- Verify whether the press release contains financial results, operational updates, guidance, financing activity, or material risk disclosures.
- Confirm the company’s Form 20-F reporting status and subsequent SEC filings for additional financial information.